BENDAMUSTINE ACCORD

2,5MG/ML INF PLV CSL 5X25MG

SÚKL code 0129693
Name of the product BENDAMUSTINE ACCORD
_MA_MEDICATION_DETAIL_INFO_MED_NAME i BENDAMUSTINE ACCORD
Supplement 2,5MG/ML INF PLV CSL 5X25MG
Strenght 2,5MG/ML
Pharmaceutical form Powder for concentrate for solution for infusion
Package 5X25MG
Route Intravenous use
Language of the pack Czech
Wrap type Vial
Legal status na lékařský předpis
Active substance BENDAMUSTINE HYDROCHLORIDE MONOHYDRATE (BENDAMUSTINI HYDROCHLORIDI MONOHYDRICUM)
ATC group L01AA09
ATC group name BENDAMUSTIN
Doping Diuretika a ostatní maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/.

Marketing authorisation information

Registration Number 44/ 594/15-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 09. 2019
MA Holder Accord Healthcare Limited, North Harrow
MA Holder country VELKÁ BRITÁNIE
Actual MA holder ACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
Actual MA holder country POLSKO

Back to list